[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-13", "acceptance_datetime": "2025-11-13T21:29:31Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001774857", "sic": "2834", "tickers": ["AARD"], "company_name": "Aardvark Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001193125-25-280260", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001193125-25-280260/files/ck0001774857-20250930_htm.xml", "financials": {"income_statement": {"diluted_average_shares": {"value": 21713858.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "nonoperating_income_loss": {"value": 1387000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "basic_earnings_per_share": {"value": -0.75, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "diluted_earnings_per_share": {"value": -0.75, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "other_operating_expenses": {"value": 3966000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_after_tax": {"value": -16316000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "revenues": {"value": 1351000.0, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 19054000.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_income_loss": {"value": -17703000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 13737000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_average_shares": {"value": 21713858.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "income_loss_from_continuing_operations_before_tax": {"value": 1351000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -16316000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 17703000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -16316000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_and_dividend_income_operating": {"value": 1351000.0, "unit": "USD", "label": "Interest And Dividend Income, Operating", "order": 2600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -16316000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -16231000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -16231000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -16231000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"other_current_liabilities": {"value": 4142000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "noncurrent_assets": {"value": 4022000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 133229000.0, "unit": "USD", "label": "Assets", "order": 100}, "cash": {"value": 126400000.0, "unit": "USD", "label": "Cash", "order": 210}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "equity_attributable_to_parent": {"value": 122377000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 10852000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "temporary_equity_attributable_to_parent": {"value": 0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}, "other_current_assets": {"value": 2807000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "current_liabilities": {"value": 10736000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "accounts_payable": {"value": 4444000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity": {"value": 122377000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 133229000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 116000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "wages": {"value": 2150000.0, "unit": "USD", "label": "Wages", "order": 730}, "current_assets": {"value": 129207000.0, "unit": "USD", "label": "Current Assets", "order": 200}}}}, {"start_date": "2025-04-01", "end_date": "2025-07-01", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001774857", "sic": "2834", "tickers": ["AARD"], "company_name": "Aardvark Therapeutics, Inc.", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": -136925000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 136925000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity": {"value": 136925000.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": -136925000.0, "unit": "USD", "label": "Liabilities", "order": 600}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-14", "acceptance_datetime": "2025-05-14T20:50:30Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001774857", "sic": "2834", "tickers": ["AARD"], "company_name": "Aardvark Therapeutics, Inc.", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0000950170-25-071560", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0000950170-25-071560/files/ck0001774857-20250331_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities_continuing": {"value": -11388000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -35137000.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 88875000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -112624000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -11388000.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 88875000.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -112624000.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -35137000.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"nonoperating_income_loss": {"value": 1160000.0, "unit": "USD", "label": "Nonoperating Income/Loss", "order": 900}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -9310000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 2715000.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 13194718.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "interest_and_dividend_income_operating": {"value": 1175000.0, "unit": "USD", "label": "Interest And Dividend Income, Operating", "order": 2600}, "net_income_loss": {"value": -9310000.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "diluted_earnings_per_share": {"value": -0.71, "unit": "USD / shares", "label": "Diluted Earnings Per Share", "order": 4300}, "income_loss_from_continuing_operations_after_tax": {"value": -9310000.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -9310000.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -9310000.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "diluted_average_shares": {"value": 13194718.0, "unit": "shares", "label": "Diluted Average Shares", "order": 4500}, "operating_expenses": {"value": 10470000.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -10470000.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 7755000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "basic_earnings_per_share": {"value": -0.71, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": -9266000.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -9266000.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -9266000.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"cash": {"value": 151300000.0, "unit": "USD", "label": "Cash", "order": 210}, "accounts_payable": {"value": 2556000.0, "unit": "USD", "label": "Accounts Payable", "order": 710}, "equity_attributable_to_parent": {"value": 150689000.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "wages": {"value": 498000, "unit": "USD", "label": "Wages", "order": 730}, "liabilities": {"value": 6336000.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity": {"value": 150689000.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 360000, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "temporary_equity": {"value": 0, "unit": "USD", "label": "Temporary Equity", "order": 1700}, "assets": {"value": 157025000.0, "unit": "USD", "label": "Assets", "order": 100}, "temporary_equity_attributable_to_parent": {"value": 0, "unit": "USD", "label": "Temporary Equity Attributable To Parent", "order": 1800}, "other_current_liabilities": {"value": 2922000.0, "unit": "USD", "label": "Other Current Liabilities", "order": 740}, "other_current_assets": {"value": 3254000.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_assets": {"value": 2471000.0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 154554000.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities_and_equity": {"value": 157025000.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_liabilities": {"value": 5976000.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}}}]